亚洲药公司的销售额和利超过第一季度预期,收入增长了8%. AstraZeneca exceeded Q1 sales and profit expectations with an 8% revenue increase.

由于对癌症治疗的强需求,阿斯特拉泽内卡公司销售额和利超过了第一季度预期,收入增长8%至152.9亿美元. AstraZeneca exceeded first-quarter sales and profit expectations, reporting an 8% revenue increase to $15.29 billion, driven by strong demand for cancer treatments. 公司维持全年预期,预计收入增长率为中高一位数,每股收益低两位数. The company maintained its full-year outlook, forecasting mid-to-high single-digit revenue growth and low double-digit earnings per share gains at constant currencies. 首席执行官帕斯卡·索里奥 (Pascal Soriot) 表示,公司仍在实现到2030年达到800亿美元的年度销售目标. CEO Pascal Soriot stated the company remains on track to reach its $80 billion annual sales target by 2030.